FDA Chemist Faces New Charges Before Possible Plea Deal
U.S. Food and Drug Administration chemist Cheng Yi Liang was hit with additional charges Monday over his alleged $3.7 million insider trading scheme involving pharmaceutical stocks, a development that prosecutors had...To view the full article, register now.
Already a subscriber? Click here to view full article